![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 32, 24630-24638, August 11, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, April 17, 2000, and in revised form, May 5, 2000
An expression library for active site mutants of
human topoisomerase II Type II DNA topoisomerases are essential cellular enzymes that are
required for cell proliferation. They catalyze topological change of
DNA molecules through the transient breakage and rejoining of
double-stranded DNA; mechanistically, the enzyme makes a gate in one
double-strand DNA segment and allows another DNA segment to pass
through the gate. These reactions relax supercoiled DNA and catenate or
decatenate covalently closed circular DNA molecules (1). In addition,
type II DNA topoisomerases are clinical targets for antibiotics and
anticancer drugs.
Prokaryotic DNA TOP2, also known as DNA gyrase, is composed of two
subunits, A protein (GyrA) and B protein (GyrB), and the active form is
an A2B2 heterodimer. Eukaryotic
TOP21 is a homodimer composed
of a monomer with two domains, B' and A', corresponding to DNA gyrase B
and A subunits, respectively (2). All TOP2 enzymes share sequence
similarity (3); in addition, similarity has been observed in the x-ray
crystal structures of TOP2 proteins (4, 5). Because TOP2 is conserved
through evolution, limited genetic interchangeability for TOP2 from
different species is observed (6-8).
The enzymatic mechanism of TOP2 has been studied extensively, and it is
thought to involve multistep conformation changes of the enzyme (9).
Because only a small number of crystal structures of TOP2 have been
published, it is difficult to understand the enzymatic mechanism fully
from this structural information alone. However, biochemical
experiments have been carried out to provide information on the
interactions between the enzyme and its DNA substrate. For example,
Worland and Wang (10) showed that the active site Tyr783
attaches covalently to the 5' end of the cleaved DNA chain. Recent work
on DNA gyrase suggested specific interactions between the enzyme and
its DNA substrate at distinct steps of the catalytic cycle by probing
the topology of the enzyme-bound DNA segment (11).
To understand enzymes and their biological function, it is important to
characterize both their catalytic and their structural properties.
Several experimental approaches are commonly used for this purpose. One
approach is to determine the primary structures (i.e.
protein sequences) of related proteins from different species and align
them with one another. Such a sequence alignment is useful to identify
the evolutionarily conserved amino acids and motifs that may play
functional roles in a group of related proteins. X-ray crystallography
and nuclear magnetic resonance are used to study the three-dimensional
structure of a protein at the atomic level. These structural methods
provide information on the structure of the entire protein and its
subdomains and subunits. Such information is necessary to understand
how enzymes interact with substrates, other molecules, inhibitors, and
activators, etc., and to evaluate the biological roles of the proteins
in vivo. Once a structural model is available, site-directed
mutagenesis of specific residues is often undertaken to determine the
structure/function relationships of the protein in detail.
Ala scanning is a commonly used mutagenesis approach, in which protein
residues of interest (i.e. in the active site, ligand binding site, or protein interface) are systematically changed one by
one from their identity in the wild type protein to Ala in a
corresponding mutant. This is useful to create mutant proteins, but the
effects of specific amino acid substitutions are not generally predictable. Another approach is to randomly mutagenize a codon or
group of codons by random substitution of nucleotides; the group of
mutants can then be subjected to genetic selection (12, 13). If a
particular property of a side chain (length, hydrophobicity, etc.) is
important at a given position, only side chains with conservative amino
acid substitutions will be allowed in functional mutants
(i.e. those that survive the selection process). This method
reinforces the interpretation of x-ray crystal structures and helps to
define the functional roles of each amino acid residue in
vivo.
Such mutagenesis studies have exclusively used Escherichia
coli as the host for expression and selection of mutant proteins. Large numbers of mutant proteins are easily analyzed in E. coli; however, high molecular weight mammalian enzymes that are
not able to be expressed in E. coli cannot be analyzed by
this approach in this host. In the present study, random mutagenesis
was carried out on human topoisomerase 2 Strains, cDNA, and Oligonucleotides--
The
yeast strain SD1-4 (MATa, ade1, ade2, ura3-52,
top2-1) was kindly provided by Dr. S. DiNardo (State University of
New York), and JN394t2-4 (MATa, ura3-52, leu2, trp1, his7,
ade1-2 ISE2, rad52::LEU2 top2-4) was provided by J. Wang (Harvard University). A full length of human TOP2 Plasmid Constructions--
The short
XbaI-HindIII fragment of pYES2 (Invitrogen,
Groningen, Netherlands) was replaced with a synthetic oligomer 5'-CTA GGC TCG AGA TGC TAC GTA AGT CAG CCC GGG CTG CGG CCG CT, which is
annealed with 5'-AGC TAG CGG CCG CAG CCC GGG CTG ACT TAC GTA GCA TCT
CGA GC (LLpYES-PGAL1). LLpYES-PGAL1 contains a new restriction site for
NotI and lacks XbaI and KpnI sites.
The full length of human TOP2
Nonfunctional Dummy TOP2 Random Oligonucleotides--
An equimolar mixture of random
oligonucleotides was made from 16 synthetic oligomer pools with
substitutions at codons 788-813 of human TOP2 Library Construction--
To construct a human TOP2
The KpnI-XbaI large fragment of the LLpYES
hTOP2DUM-PGAL1 and the Randomized Cassette were ligated and used for
transformation of DH5 Complementation Assay--
The yeast strain SD1-4 was used for
transformation with the human TOP2 DNA Sequencing--
The target regions of active mutants were
sequenced using the Taq Dye Terminator Cycle Sequence Kit,
with a Perkin-Elmer-Applied Biosystems 373A DNA Sequencer (Foster City,
CA). An oligomer, 5'-GACAGTGGTGAAATGT, was used for the sequencing primer.
Complementation Assay Using the Independent
Libraries--
Construction of independent libraries and
complementation assays were carried out using the same procedures as
described above, except that each single random oligomer was used for
the library construction. Each library contains 64 codon variations at
the targeted position.
Site-directed Mutagenesis--
CelII restriction
sites outside the TOP2 Etoposide Resistance Assay--
To investigate etoposide
resistance, the permeable yeast strain JN394top2-4 was transformed by
the functional mutants of human TOP2 Construction of Yeast Expression Library for Mutants of Human
TOP2
Sixteen oligonucleotide pools were synthesized that are complementary
to the 78 bases around the TOP2 active site. Each oligonucleotide pool
contains randomized nucleotides at one of the 16 codons in amino acids
793-808. A 380-base pair fragment of the TOP2 gene was amplified using
a mixture of these 16 "mutant" oligonucleotide pools as one PCR
primer and a wild type oligonucleotide as the other PCR primer. The PCR
product was purified, digested by KpnI and XbaI,
and used to replace the same restriction fragment of the Dummy Vector
(see "Experimental Procedures"). In theory, the library of plasmids
recovered from ligating the PCR product with the Dummy Vector direct
synthesis of wild type human TOP2 and 19 single amino acid substitution
mutants at each residue in the targeted region in human TOP2 Genetic Selection of Functional Human TOP2
In vivo selection was carried out to identify functional
human TOP2 Active Mutants of Human TOP2
Among the 98 active mutants of TOP2
The amino acid substitutions were not random. Leu798,
Ser802, and Pro803 were among the residues that
were most tolerant of variation; active mutants were selected in which
these residues were replaced by amino acids with variable charge and
side chain lengths. In contrast, Leu794,
Gly797, Asp799, Ala801,
Arg804, Tyr805, Ile806,
Phe807, and Thr808 tolerated only subtle
changes (Fig. 5B) and tended to be unchanged or were
replaced only by very similar amino acids (conservative changes);
however, silent mutations were found in the codons for Arg804 and Phe807 (Fig. 5A).
Active Mutants in Independent Libraries--
Amino acids that
allow only limited substitution without resulting in loss of enzyme
activity may play a strictly defined role in the function of that
protein (12, 13, 15). Although the initial screen described above
identified 50 allowable amino acid substitutions in active variants of
human TOP2
All active clones isolated from the library of mutants at
Tyr805 library had a Tyr residue at the targeted position
(Fig. 6B). Because a Dummy Vector was used to construct
these libraries, wild type clones cannot be contaminated by incomplete
restriction digestion. Therefore, the active variants with a Tyr codon
at 805 were generated from the randomly substituted oligonucleotide pool. In the Tyr805 random mutant library, it is predicted
that 6.3 Tyr codons would be found among the 200 colonies screened
(assuming the library contains all codons in equimolar proportions).
Consistent with this prediction, six wild type clones were identified
by screening the Tyr805 mutant library (Fig.
6A).
Among the other amino acids studied, four positions allowed only
conservative substitutions to conserve enzyme activity (16). Leu794 could be substituted with Ile or Val, the other two
aliphatic side chains. Asp799 could be substituted with the
acidic side chain of Glu, Ala801 could be substituted with
the small amino acids Gly and Ser, and Arg804 could be
substituted with the basic amino acid Lys (Fig. 6B). These
data show that Tyr805 is immutable and that
Leu794, Asp799, Ala801, and
Arg804 are nearly immutable residues of human TOP2 Mutants That Are Resistant against Etoposide--
By screening
these nine libraries of mutants at individual codons in the active site
of human TOP2 Tolerance to Amino Acid Substitutions in the Genetic
Complementation--
We have introduced single amino acid
substitutions into the 16 amino acids around the active site of the
enzyme, and these mutant enzymes were used to complement a TOP2
temperature-sensitive mutation in S. cerevisiae. Tolerance
to amino acid substitutions at each residue was determined by using
libraries including either a mixture of mutants at the 16 targeted
amino acids or including mutants at only one of the 16 targeted amino
acid residues (Figs. 5 and 6).
The results of the complementation assay suggest that the targeted
amino acids can be categorized into four groups. The first group
includes only one member, the active site Tyr805. This Tyr
residue is involved in transesterification to the DNA phosphodiester
bond; no active mutant could be isolated with any substitution in this
position in experiments with the mixed codon and the single codon
targeted mutant libraries. As shown in Fig. 3, the plasmid libraries
include variants that synthesize proteins with amino acid substitutions
at these positions; however, these nonfunctional substitutions do not
complement the temperature-sensitive yeast host strain. Such mutants
were also reported previously and were created by site-directed
mutagenesis at this site. For example, a DNA topoisomerase IV mutant
that has a conservative substitution of His for Tyr805
carries out nicking of single-stranded DNA but does not carry out
double-stranded DNA cleavage (18). That study agrees with the results
presented here, in that it also demonstrates a strict requirement for a
Tyr residue at position 805 to retain TOP2 activity.
The second group of residues identified in this mutant screen includes
Leu794, Asp799, Ala801, and
Arg804; these four residues were susceptible to
conservative amino acid substitutions. Leu794 can be
substituted with other aliphatic amino acids, Asp799 can be
substituted with another acidic side chain Glu, Ala801 can
be substituted with amino acids Gly and Ala that are small, and
Arg804 can be substituted with another basic side chain Lys
(Fig. 6B). These amino acids play such important roles in
enzyme function that only extremely limited substitutions can occur
without loss of catalytic efficiency. Arg804 is immediately
adjacent to the active site Tyr805. In DNA gyrase, a
similar set of amino acids has been proposed to form the active site of
the breakage-reunion reaction (5). In addition, Arg781 from
S. cerevisiae TOP2, which corresponds to Arg804
in the human enzyme, has been subjected to site-directed mutagenesis (19). The results of that study suggest that Arg781 might
be involved in anchoring the 5' side of the broken DNA (19). Our
results are consistent with those results and also demonstrate that
another basic residue, Lys, could substitute for Arg at this position,
although Arg is strictly conserved in naturally occurring proteins from
various species (Fig. 1). Interestingly, in this group of four residues
that allow conservative substitutions, Ala801 and
Arg804 are highly conserved in all species including
prokaryotes, whereas Leu794 and Asp799, which
are located farther from the active site, are conserved only in higher
eukaryotes in the primary structure.
The last two categories of residues in the active site region of human
TOP2 Etoposide-resistant Mutants--
It was somewhat surprising to
find that Lys798 was highly mutable by this screening
procedure. It has been proposed that the corresponding residue in
S. cerevisiae TOP2 interacts with the single-stranded region
of the substrate DNA (19, 20). If this interaction were to be
essential, it would be predicted that Lys798 would be
relatively immutable. One possible explanation is that Lys798 is involved in an interaction with DNA but that this
interaction is dispensable for efficiency of the catalytic functions.
Such interactions have been described in Taq DNA polymerase
I. For example, Thr664 in this polymerase interacts with
the template DNA in the closed ternary complex (21) and was highly
mutable in a genetic complementation assay (15). However, the
substitution was not totally without effect on the enzyme, because it
decreased the fidelity in DNA replication (22). If a comparable
situation applies to Lys798 of TOP2, then some mutants of
Lys798 may have altered biochemical properties that have
not been identified in this study.
Support for the above hypothesis was found by testing the active
variants of TOP2 Implication for a Structural Model of TOP2
Fig. 8 shows the locations of human amino
acid residues Arg793-Thr808 on a schematic
diagram of the S. cerevisiae TOP2 polypeptide backbone. Side
chains are shown in four colors as categorized above: red,
purple, yellow, and light blue for
groups 1 (immutable), 2 (conservative substitutions only), 3 (highly
mutable, but not to charged side chains), and 4 (highly mutable),
respectively. In S. cerevisiae TOP2, the first three
targeted amino acids are in the
In wild type human TOP2
The four amino acids (Leu794, Asp799,
Ala801, and Arg804) and the active site
Tyr805 must be functionally important because they are well
conserved or unchangeable and because they form a plane on the
polypeptide backbone (Fig. 8B). In the crystal structure of
DNA gyrase A, Morias Cabral et al. (5) modeled a
double-stranded DNA substrate on the surface of the protein and found
that the active Tyr residues of each GyrA subunit, located
approximately 27 Å apart, must move to achieve appropriately staggered
positions for cleavage of the 5' ends of the duplex. In DNA gyrase A,
the side chain positions of Ala118, Arg121, and
Tyr122 can be superimposed on the corresponding positions
of Ala801, Arg804, and Tyr805 (data
not shown). Interestingly, Leu794 and Asp799 of
human TOP2
The etoposide-resistant clones identified in this study may support
this model. In bacterial DNA gyrases that are sensitive to synthetic
quinolone compounds (33, 34), resistant mutants have been mapped near
the putative interaction site with DNA (5). Human TOP2
Our model is also consistent with the co-crystal structures of proteins
that share the winged-helix motif with TOP2 (5, 24). In the
HNF-3/fork head DNA recognition motif (36), a part of
the wing (W1) of HNF-3, which may be structurally homologous to
the target loop structure in human TOP2
In the absence of any binary structures of human TOP2 We thank J. Wang for helpful discussion and
for providing the co-ordinates of the putative TOP2-DNA interactions
(19). We are also grateful to Tazuko Tomita for technical assistance.
*
This work was supported by grants-in-aid from the Ministry
of Education, Science, Sports, and Culture of Japan (to A. K., Y. N., and S. Y.) and by funds from the Nitto Foundation (to
M. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, May 11, 2000, DOI 10.1074/jbc.M003243200
2
Y. Okada, A. Tosaka, A. Kikuchi, Y. Nimura, S. Yoshida, and M. Suzuki, manuscript in preparation.
The abbreviations used are:
TOP2, topoisomerase
II;
PCR, polymerase chain reaction.
Assignment of Functional Amino Acids around the Active Site of
Human DNA Topoisomerase II
*
,
,
First Department of Surgery and the
Laboratories of § Cancer Cell Biology and ¶ Medical
Mycology, Research Institute for Disease Mechanism and Control, Nagoya
University School of Medicine, Nagoya, 466-8550, Japan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(TOP2
) was constructed by replacing the
sequence encoding residues 793-808 with a randomized oligonucleotide
cassette. This plasmid library was transformed into a
temperature-sensitive yeast strain (top2-1), and viable
transformants were selected at the restrictive temperature. Among the
active TOP2
mutants, no substitution was allowed at
Tyr805, the 5' anchor of the cleaved DNA, and only
conservative substitutions were allowed at Leu794,
Asp797, Ala801, and Arg804. Thus,
these 5 residues are critical for human TOP2
activity, and the
remaining mutagenized residues are less critical for function. Using
the x-ray crystal structure of yeast TOP2 as a structural model, it can
be deduced that these 5 functionally important residues lie in a plane.
One of the possible functions of this plane may be that it interacts
with the DNA substrate upon catalysis. The side chains of
Ser803 and Lys798, which confer drug
resistance, lie adjacent to this plane.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(TOP2
). To characterize
mutants of TOP2
, they were expressed in a yeast strain carrying a
temperature-sensitive endogenous yeast TOP2, which can be genetically
complemented by the gene encoding wild type human TOP2
. This
mutagenesis study specifically targets amino acid residues
793-808 around the active site of human TOP2
. This highly conserved
region is of particular interest because it is involved in both
catalytic activity and drug sensitivity. The results presented here
provide useful information on the roles of these active site residues.
Based on the amino acid substitutions allowed in active mutants and
their drug sensitivity profiles, possible functions of the targeted
amino acid residues are proposed and discussed.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
cDNA was
also from J. Wang. E. coli DH5
(deoR,
endA1, gyrA96, hsdR17
(rk
mk+), recA1,
relA1, supE44, thi-1,
(lacZYA-argFV169),
80
lacZM15, F
, 
) was used for cloning and plasmid
constructions. DNA oligomers were synthesized and purified by Amersham
Pharmacia Biotech or NK products (Osaka, Japan).
cDNA was transferred into the large
NotI-XhoI fragment of LLpYES-PGAL1 (LLpYES
hTOP2-PGAL1).
was constructed by insertion of a synthetic
oligomer 5'-GTT ACC ATC GCA TGC AAG CTT GCT CAG C (DUM-U) annealed with
5'-GCT GAG CAA GCT TGC ATG CGA TGG TAC C (DUM-D) in the large
HpaI-KpnI fragment of PSL1190hTOP2. The
NotI-XhoI fragment was further replaced with the
corresponding site of LLpYES hTOP2-PGAL1 (LLpYES hTOP2DUM-PGAL1 or
Dummy Vector).
, 5'-GGT CAG TTT GGT
ACC (AGG CTA CAT GGT GGC AAG GAT TCT GCT AGT CCA CGA TAC ATC TTT ACA)
ATG CTC AGC TCT TTG. In each primer, either one of the target codons,
between Arg793 and Thr808, shown in parentheses
in the above sequence, was randomized by including all four nucleotides
in equimolar amounts at the appropriate synthetic cycle. We also
introduced a silent mutation at a codon downstream of each target for
15 out of 16 random oligomers (Arg793-Phe807).
Two silent mutations in Arg793 and His795 were
placed in the random oligomer that targeted residue Thr808.
For example, the Arg793 random oligomer had the sequence
5'-GGT CAG TTT GGT ACC NNN CTg CAT GGT GGC AAG GAT TCT GCT AGT CCA CGA
TAC ATC TTT ACA ATG CTC AGC TCT TTG, where the N represents an
equimolar mixture of the G, C, A, and T and the lowercase letter g
denotes a silent mutation. The silent mutations were used to identify
the origins of the oligomer when the wild type sequence was restored
during synthesis. As a result, the random oligonucleotides
theoretically contain equimolar amount of the 1024 possible mutations
as single amino acid substitutions.
mutant
plasmid library, the mixture of random oligonucleotides was used as a
forward PCR primer. A reverse primer was designed complementary to the
XbaI site of hTOP2cDNA sequence (5'-CAT GGG TTC TAG AAC
TTG TTC). Using PSL1190hTOP2, as a template, 25 cycles of PCR (94 °C
for 30 s, 45 °C for 30 s, and 72 °C for 30 s) were
carried out using the proofreading-competent Pyrobest DNA polymerase
(TaKaRa, Kyoto, Japan) with appropriate buffers. The 380-base pair PCR
product was isolated by electrophoresis in a 0.8% agarose gel and
purified by QIAEXII gel extraction kit (Qiagen, Valencia, CA). This
fragment was treated with restriction enzymes KpnI and
XbaI, and purified again by the same procedure (Randomized
Cassette). In some experiments, one of 16 random oligomers was used as
a primer for library construction (see below).
. An aliquot of the transformed E. coli was plated on 2× YT (16 g/liter tryptone, 10 g/liter
yeast extract, 5 g/liter NaCl, pH 7.3) containing carbenicillin (100 µg/ml) to determine the total number of transformants, and the
remainder was inoculated into 500 ml of 2× YT and cultured at 37 °C
overnight. Plasmids were recovered and used as a mutant plasmid
library. The random library consists of approximately 6000 independent clones.
mutant plasmid library by
Frozen-EZ Yeast Transformation II (Zymo Research, Orange, CA). The
transformants were cultured on solid medium, SD-URA (6.7 g/liter yeast
nitrogen base without amino acids, 5 g/liter casamino acids, 20 g/liter
glucose, 20 mg/liter adenine sulfate, 20 mg/liter tryptophan, 15 g/liter Bacto agar) at 25 °C for 48 h, replicated on a plate
containing SDGAL-URA by using Replica Plater (TaKaRa, Kyoto, Japan), in
which glucose of the SD-URA medium was replaced by 20 g/liter
galactose. The replicated colonies were cultured at 37 °C for 7 days. Colonies were picked and cultured in tubes with 2 ml of SD-URA at
25 °C overnight. The yeast cells were collected, resuspended in 200 µl of lysis buffer (2% Triton X-100, 1% SDS, 100 mM
NaCl, 10 mM Tris-HCl, and 1 mM
Na2EDTA), and lysed by vigorous mixing for 10 min with 300 mg of acid-washed glass beads (300 microns; Sigma) and 200 µl of
Phenol CIA (phenol:chloroform:isoamyl alcohol = 25:24:1, mixed pH
6.7; Nacalai Tesque, Kyoto, Japan). After centrifugation and
ethanol precipitation, the purified DNA was used for transformation of
DH5
by electroporation according to Bio-Rad. The transformed cells
were incubated on 2× YT plate containing carbenicillin (100 µg/ml)
at 37 °C overnight. Colonies were picked up and inoculated into 2 ml
of 2× YT solution containing carbenicillin (100 µg/ml) at 37 °C
overnight. Plasmids were extracted and purified by Wizard Plus Mini
Preps DNA purification system (Promega, Madison, WI) and used for a
second transformation of the SD1-4 strain to confirm colony formation.
gene of the Dummy Vector were knocked out by
a CelII partial restriction and treatments with Klenow
fragment and T4 ligase. Oligomers between the KpnI and
CelII sites of human TOP2
with desired mutations were
chemically synthesized and used for replacement with the corresponding
fragment of the Dummy Vector.
by means of electroporation
(Gene Pulser II, Richmond, CA). After 7 days of culture on SD-URA
plates at 25 °C, each transformant was picked and streaked on
SDGAL-URA plate with or without etoposide (100 µg/ml; Sigma).
Etoposide resistance was determined after culture at 35 °C for 7 days.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
--
The primary and secondary structures of the active site
region of TOP2 are conserved among species from bacteria to human (Fig.
1 and Refs. 3-5) and are essential for
catalysis (1). The active site includes a critical tyrosine residue
that becomes covalently linked to DNA during catalysis
(Tyr805 in human TOP2
). In Saccharomyces
cerevisiae TOP2, this active site Tyr residue is located at the
C-terminal edge of a loop structure on the surface of the A' domain
(4). To study the functions of individual residues in this region of
human TOP2
, random substitutions were made for amino acids 793-808,
and mutants with enzymatic activity were selected by genetic
complementation (Fig. 2).

View larger version (24K):
[in a new window]
Fig. 1.
Amino acid alignment of the active site
region of TOP2. Amino acid sequences of topoisomerase II from
various species were obtained from EMBL. The numbers at the
top of the figure represents the amino acid number of human
TOP2
from 793 (Arg) to 808 (Thr), corresponding to that from 771 to
786 in S. cerevisiae and to that from 110 to 125 in E. coli. Dm, Drosophila melanogaster;
Sc, S. cerevisiae; Sp,
Schizosaccharomyces pombe; Tryp,
Trypanosoma brucei; Cfa, Crithidia
fasciculata; GyrA, gyraseA; Ec, E. coli; Kp, Klebsiella pneumoniae;
Bs, Bacillus subtilis; Mp,
Mycoplasma pneumoniae; Sa, Staphylococcus
aureus.

View larger version (23K):
[in a new window]
Fig. 2.
Selection strategy. The random
oligonucleotide mixture and a reverse primer were designed for
amplifying the 380-base pair fragment of TOP2 by Pyrobest DNA
polymerase. This randomized cassette was used to replace the
corresponding region of the Dummy Vector. The plasmid library,
containing 6000 independent mutant clones, was transferred into the
temperature-sensitive yeast strain SD1-4. Other conditions were
described under "Experimental Procedures."
.
However, the representation of different mutants in the library depends
on the efficiency of synthesis of each mutant oligonucleotide and the
efficiency with which it is used in the PCR reaction. To test the
actual composition of the library, 49 clones were arbitrarily selected,
and their DNA sequences were determined (Fig.
3). All theoretically possible mutations
were found within the randomized region, and all isolates had single
amino acid substitutions at 13 positions of 16. Although in five cases
the same substitutions were recovered twice, each contained different
nucleotide sequences with a few exceptions (i.e. two Leu
substitutions at Asp799 and two Gly substitutions at
Ser802).

View larger version (10K):
[in a new window]
Fig. 3.
Mutations in the mixed random library in
E. coli. Forty-nine samples from the mixed random
library in E. coli DH5
were cloned and sequenced. The
amino acid positions of human TOP2
are indicated at the
top. All substitutions represent single amino acid
replacements. Silent substitutions are listed in italics.
When the same amino acid substitution was isolated more than once, the
number of isolates is also indicated.
Mutants--
The
temperature-sensitive S. cerevisiae strain SD1-4
(top2-1) was used to select active variants of TOP2 from the
library of mutants by in vivo complementation assay.
Previous studies have demonstrated that the temperature-sensitive
phenotype in yeast can be complemented by transformation with a plasmid
that expresses either mouse (6) or human TOP2 (14). A plasmid that
expresses wild type human TOP2
also suppresses the
temperature-sensitive phenotype of SD1-4 at 37 °C, although a
plasmid expressing an inactive human TOP2
(i.e. Y805L) or
the vector alone, does not complement the host strain (Fig.
4).

View larger version (84K):
[in a new window]
Fig. 4.
Functional complementation of a
TOP2ts yeast strain SD1-4 by human
TOP2
. S. cerevisiae SD1-4
(top2-1) was transformed with a vector pYES,
LLpYEShTOP2DUM-PGAL1, which carries inactive TOP2
;
LLpYEShTOP2-PGAL1, which carries wild type human TOP2
; or
LLpYES-PGAL1-Y805L, which carries a mutant TOP2
at the active
center. Transformed cells were streaked on an SD-URA plate and
incubated at 25 °C (A) and on SDGAL-URA plate at 37 °C
(B). In between the panels, names of the clones
are indicated. LpYes, pYES2-PGAL1; Dummy, LLpYES
hTOP2DUM-PGAL1; WT, LLpYEShTOP2-PGAL1;
Y805L, Leu substitution at Tyr805.
Open arrowhead indicates the wild type culture.
mutants in the plasmid library; however, accurate
discrimination between functional and nonfunctional mutants requires a
sensitive and strict complementation specificity. To test this system
using SD1-4, cells were screened at 37 °C after being transformed
with plasmid DNA mixtures containing wild type human TOP2-expressing plasmid and the Dummy Vector at the following ratios: 100:0, 50:50, 25:75, or 0:100. Colonies were seen on plates only when the mixture included the wild type vector. Plasmid DNA was isolated from 20 individual clones from each transformation, and their sequences were
determined. All plasmids from the 100:0 mixture and 19 of 20 from the
50:50 and 25:75 mixtures were wild type plasmids. Thus, the system
provides a way to discriminate the nonfunctional clone when a
homogeneous plasmid was used for transformation, but the rate of false
positives is 5% when a mixed population of input DNA is screened. To
completely exclude nonfunctional mutants in the subsequent experiments,
each plasmid recovered from the first round of selection was subjected
to a second round of selection in the same strain. After the second
round of selection, the false positive clones were effectively removed.
--
This random library was
transformed into yeast, and 200 independent transformants were grown at
30 °C (permissive temperature). Colonies were transferred to fresh
plates by replica plating and cultured for a week at 37 °C
(restrictive temperature). Approximately half of the colonies that grew
at 37 °C also grew at 30 °C. A total of 108 plasmids were
isolated from the temperature-resistant colonies, and the DNA sequence
of the mutated region was determined. Six of the 108 plasmids
unexpectedly contained double mutations, and these were not studied
further. Four mutants did not form colonies when the plasmid was
retransformed and were regarded as false positives. As a result, 98 clones encoding active mutants of human TOP2
were obtained for
further study.
selected by this screen, there
were 83 mis-sense and 15 silent mutations. Some of the mis-sense
substitutions were nonredundant at the nucleotide or amino acid level,
so that the pool of active TOP2 mutants represented 68 different codon
substitutions and 50 different amino acid substitutions in the targeted
active site region (Fig. 5).

View larger version (27K):
[in a new window]
Fig. 5.
Compilation of amino acid substitutions using
the mixed library. SD1-4 yeast were transformed with the mixed
random libraries. The DNA sequence of the complementing clones are
indicated in triplet codons (A) and deduced amino acid
residues (B). The number of amino acid positions is as
indicated in Fig. 3. Solid triangles indicate the amino acid
residues where either no substitution or only conservative amino acid
substitutions were found. All substitutions were single amino acid
replacements. In A, the number of substitution at each amino
acid is listed under the wild type sequence. Codons and the
corresponding amino acids are at the left. Silent
substitutions are shown in italics. In B,
substituted amino acid residues at each site are listed. Silent
substitutions are not listed. When the same amino acid substitution was
isolated more than once, the number of isolates is also
indicated.
, it was not a comprehensive screen of such mutants. Using
a mixture of the 16 random cassettes as a library source, thousands of
positive clones would have to be screened, isolated, and sequenced to
make statistically valid conclusions about all possible active variants in the library. Therefore, nine additional independent libraries were
prepared, each of which included random substitution at the codon for
one of the following amino acids: Leu794,
Gly797, Asp799, Ala801,
Arg804, Tyr805, Ile806,
Phe807, and Thr808. Complementation experiments
were carried out until at least 200 transformants were screened from
each library; this number is more than three times higher than the
number required to screen one copy of each possible substitution at a
target codon (Fig. 6).

View larger version (25K):
[in a new window]
Fig. 6.
Compilation of amino acid substitutions using
the independent libraries. SD1-4 yeast was transformed using the
independent random libraries for Lys794,
Gly797, Asp799, Ala801,
Arg804, Tyr805, Ile806,
Phe807, and Thr808. Clones that complemented
the temperature-sensitive growth were sequenced. The nucleotide
sequences are shown in triplet codons (A) and deduced amino
acid residues (B) as in Fig. 5. Solid triangles
indicate the amino acids of interest. G797E and R804K were also
constructed by site-directed mutagenesis, and their activity was
confirmed by independent complementation. Based on the number of
screened transformants and silent substitutions, all the possible amino
acid substitutions were surveyed with a probability greater than 95%.
Some codons might not be isolated because of codon usage preference in
S. cerevisiae.
, as
detected by this genetic complementation assay.
, 66 functional mutants of human TOP2
were
identified in total. Because these substitutions were introduced around
the active site, these mutants are likely to include enzymes with
altered catalytic specificities and properties, such as altered drug
sensitivity. This possibility was tested by transforming the mutant
plasmids into the JN394t2-4 strain and plating the transformants on
agar plates containing 100 µg/ml etoposide. Three mutants were
selected as etoposide-resistant clones. One mutant, P803S,
showed a weak resistance to etoposide, as reported previously (7, 17).
The other mutants, K798L and K798P, also formed etoposide-resistant
colonies. The relative resistance of these mutants were in the order
K798P > K798L > P803S (Fig.
7).

View larger version (71K):
[in a new window]
Fig. 7.
Assignment of etoposide resistance in yeast
strain JN394t2-4. Wild type (WT) and mutants in human
TOP2
(K798P, K798L, K798C, and P803S) were used to transform
JN394t2-4 (ISE2, top2-4). Each clone that carries
either wild type or mutant TOP2
was cultured and streaked on an
SDGAL-URA plate with (A) or without (B) 100 µg/ml etoposide (VP16). Drug sensitivity was determined after
incubation at 35 °C for 1 week. In between the panels,
names of the clones are indicated. P803S is indicated by an open
arrowhead, and K798P and K798L are indicated by filled
arrowheads.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
are much more tolerant of amino acid substitution. Ile806 and Phe807 are tolerant to all
substitutions except those with charged side chains, and the last
group, His795, Lys798, Ser800,
Ser802, Pro803, and Thr808, are
tolerant to a variety of amino acid substitutions including alterations
in side chain length, hydrophobicity and charge. Gly796 is
tolerant of various substitutions and belongs either in the third or
fourth groups. Residues in the third or fourth group are not essential
for TOP2 function. Nevertheless, it is surprising that these residues
have not randomly drifted in the course of evolution (Fig. 1) but
instead are represented by a rather narrow ranges of amino acids in
naturally occurring TOP2 sequences. One explanation for this is that
some substitutions at these positions might have little or no direct
effect on enzyme activity but may alter other characteristics of the
enzyme, such as its sensitivity to environmental stress, that are not
evident in the screen carried out here.
identified in this study for drug resistance. Among
the three etoposide-resistant mutants that were identified, two mutants
had amino acid substitutions of Leu or Pro at Lys798 (K798L
and K798P; Fig. 7). These mutants also exhibited the resistance in an
in vitro experiment using overexpressed and purified
proteins.2 Another mutant at
this position, K798N, has been described previously; thismutation occurred during selection of a cloned human
leukemic cell line (23). However, the relationship between the
substitution and drug resistance has not been proven for K798N.
--
The amino acid
sequence of human TOP2
is nearly 50% homologous to the sequence of
S. cerevisiae TOP2 (3). Furthermore, human TOP2
is
functionally interchangeable with S. cerevisiae TOP2 in the
yeast cell (this study and Ref. 14). These results suggest that these
two proteins share a common conformation at the level of tertiary
structure, especially around the active site (i.e. at the
CAP-like folds; see Refs. 4, 24, and 25). Based on this assumption, the
functional data presented here were superimposed on structural
information for S. cerevisiae TOP2 (4).
5-helix (Fig. 8A). This
structure may also exist in human TOP2
, because the corresponding
region (Arg793-His795) is located between the
three conserved glycines at 791, 796, and 797 in both human and
S. cerevisiae enzymes. Ile806 and
Phe807 could not be substituted with any hydrophilic side
chains, which may indicate that they are buried toward the hydrophobic
interior of the molecule (26, 27). In agreement with this observation, in S. cerevisiae TOP2, the corresponding amino acids extend
toward the inside of the protein (
3 sheet; Fig. 8A). Thus
the first three and last three residues of the target loop (Fig. 1) of
human TOP2
superimpose well on the yeast TOP2 structure (Fig.
8).

View larger version (25K):
[in a new window]
Fig. 8.
Structural model of human
TOP2
. A, the winged motif of
the A' subdomain in the S. cerevisiae crystal structure
(AA702-AA792) is shown with the side chains that belong to group1
(red) and the group 2 (purple). Two amino acid
residues that are involved in etoposide sensitivity are also shown
(black). The polypeptide backbone between Arg793
and Thr808 is highlighted in gray, and the
remaining region is in green. The names of
5-helix
3-sheet, N-terminal site (N), and some of amino acids are
indicated in the figure. B, the target loop is shown in a
stereo view with all side chains. In both panels, side chains are
replaced with the corresponding human amino acid residues, and referred
to as the human positions (Arg793-Thr798). The
coordinate sets were obtained from the Protein Data Bank (38). The
drawing was made by using the program package InsightII (Molecular
Simulations Inc, San Diego, CA). The polypeptide backbone between
Arg793 and Thr808 is shown as a gray
ribbon. Red, group 1 (Tyr805);
purple, group 2 (Leu794, Asp797,
Ala801, and Arg804); yellow, group 3 (Ile806 and Phe807); light blue and
black, group 4 (Arg793, Lys798,
Ser800, Ser802, and Thr808). Among
the group 4 side chains, two that were involved in etoposide
sensitivity are shown in black (Lys798 and
Pro803).
, two Gly residues and a Pro residue are
found between Gly796 and Pro803. These two
amino acids are not favored to form either
-helix (28-30) or
-sheet (31, 32). The number of Gly and Pro residues can be further
increased by substitutions without loss of activity (K798G, K798P, and
S802G). Therefore, this region may form a random coil structure in
human TOP2
, just as seen in S. cerevisiae TOP2. Charged
residues Lys798, Asp799, and
Ser802, which were substituted by Arg (Fig. 5B),
must be exposed on the surface of the protein.
also come very close to Ile112 and
Asp115 of DNA gyrase A, respectively, in the same structure
(data not shown). Therefore, it would be an attractive picture that
this plane, including the active Tyr, performs catalysis through the conformational change in TOP2
. According to this hypothetical model,
the DNA molecule is held, cut, and rejoined on this planar surface.
is inhibited
by etoposide through formation of the cleavable complex (35), like
bacterial DNA gyrases by quinolone compounds. Therefore, amino acids
that are associated with etoposide sensitivity might come close to the
DNA substrate in this region.
, is considered to interact
with DNA. The loop stem is stabilized by
-sheet hydrogen bonding and
side chain-backbone interactions.
and the
substrate DNA, however, we do not rule out the other possibilities. For
example, an alternative explanation is that the plane is involved in
the interaction with the B' domain, although this is less likely because such amino acids may tolerate nonconservative substitutions (37). More plausible story is that some of the conservative amino acids
are required for the efficient conformational changes during the
catalysis or critical in keeping random coil structure of the loop region.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel.:
81-52-744-2456; Fax: 81-52-744-2457; E-mail:
msuzuki@tsuru.med.nagoya-u.ac.jp.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Wang, J. C.
(1996)
Annu. Rev. Biochem.
65,
635-692
2.
Lynn, R.,
Giaever, G.,
Swanberg, S. L.,
and Wang, J. C.
(1986)
Science
233,
647-649
3.
Caron, P. R., and Wang, J. C. (1994) Adv.
Pharmacol. 271-297
4.
Berger, J. M.,
Gamblin, S. J.,
Harrison, S. C.,
and Wang, J. C.
(1996)
Nature
379,
225-232
5.
Morais Cabral, J. H.,
Jackson, A. P.,
Smith, C. V.,
Shikotra, N.,
Maxwell, A.,
and Liddington, R. C.
(1997)
Nature
388,
903-906
6.
Adachi, N.,
Miyaike, M.,
Ikeda, H.,
and Kikuchi, A.
(1992)
Nucleic Acids Res.
20,
5297-5303
7.
Hsiung, Y.,
Jannatipour, M.,
Rose, A.,
McMahon, J.,
Duncan, D.,
and Nitiss, J. L.
(1996)
Cancer Res.
56,
91-99
8.
Wyckoff, E.,
and Hsieh, T. S.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
6272-6276
9.
Fass, D.,
Bogden, C. E.,
and Berger, J. M.
(1999)
Nat. Struct. Biol.
6,
322-326
10.
Worland, S. T.,
and Wang, J. C.
(1989)
J. Biol. Chem.
264,
4412-4416
11.
Kampranis, S. C.,
Bates, A. D.,
and Maxwell, A.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8414-8419
12.
Bowie, J. U.,
Reidhaar-Olson, J. F.,
Lim, W. A.,
and Sauer, R. T.
(1990)
Science
247,
1306-1310
13.
Dube, D. K.,
and Loeb, L. A.
(1989)
Biochemistry
28,
5703-5707
14.
Wasserman, R. A.,
Austin, C. A.,
Fisher, L. M.,
and Wang, J. C.
(1993)
Cancer Res.
53,
3591-3596
15.
Suzuki, M.,
Baskin, D.,
Hood, L.,
and Loeb, L. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9670-9675
16.
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, p. D.6, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
17.
Mao, Y., Yu, C.,
Hsieh, T. S.,
Nitiss, J. L.,
Liu, A. A.,
Wang, H.,
and Liu, L. F.
(1999)
Biochemistry
38,
10793-10800
18.
Yokochi, T.,
Kato, J.,
and Ikeda, H.
(1996)
Genes Cells
1,
1069-1075
19.
Liu, Q.,
and Wang, J. C.
(1998)
J. Biol. Chem.
273,
20252-20260
20.
Li, W.,
and Wang, J. C.
(1997)
J. Biol. Chem.
272,
31190-31195
21.
Li, Y.,
Korolev, S.,
and Waksman, G.
(1998)
EMBO J.
17,
7514-7525
22.
Suzuki, M.,
Avicola, A. K.,
Hood, L.,
and Loeb, L. A.
(1997)
J. Biol. Chem.
272,
11228-11235
23.
Patel, S.,
and Fisher, L. M.
(1993)
Br. J. Cancer
67,
456-463
24.
Berger, J. M.,
Fass, D.,
Wang, J. C.,
and Harrison, S. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7876-7881
25.
Liu, Q.,
and Wang, J. C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
881-886
26.
Perutz, M. F.,
and Lehmann, H.
(1968)
Nature
219,
902-909
27.
Rennell, D.,
Bouvier, S. E.,
Hardy, L. W.,
and Poteete, A. R.
(1991)
J. Mol. Biol.
222,
67-88
28.
Aurora, R.,
Srinivasan, R.,
and Rose, G. D.
(1994)
Science
264,
1126-1130
29.
Kamtekar, S.,
Schiffer, J. M.,
Xiong, H.,
Babik, J. M.,
and Hecht, M. H.
(1993)
Science
262,
1680-1685
30.
Richardson, J. S.,
and Richardson, D. C.
(1988)
Science
240,
1648-1652
31.
Minor, D., Jr.,
and Kim, P. S.
(1994)
Nature
367,
660-663
32.
Chou, P. Y.,
and Fasman, G. D.
(1974)
Biochemistry
13,
211-222
33.
Hooper, D. C.,
and Wolfson, J. S.
(1991)
Eur. J. Clin. Microbiol. Infect. Dis.
10,
223-231
34.
Ferrero, L.,
Cameron, B.,
Manse, B.,
Lagneaux, D.,
Crouzet, J.,
Famechon, A.,
and Blanche, F.
(1994)
Mol. Microbiol.
13,
641-653
35.
Chen, A. Y.,
and Liu, L. F.
(1994)
Annu. Rev. Pharmacol. Toxicol.
34,
191-218
36.
Clark, K. L.,
Halay, E. D.,
Lai, E.,
and Burley, S. K.
(1993)
Nature
364,
412-420
37.
Bowie, J. U.,
and Sauer, R. T.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
2152-2156
38.
Bernstein, F. C.,
Koetzle, T. F.,
Williams, G. J.,
Meyer, E., Jr.,
Brice, M. D.,
Rodgers, J. R.,
Kennard, O.,
Shimanouchi, T.,
and Tasumi, M.
(1977)
Eur. J. Biochem.
80,
319-324
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Duca, D. Guianvarc'h, K. Oussedik, L. Halby, A. Garbesi, D. Dauzonne, C. Monneret, N. Osheroff, C. Giovannangeli, and P. B. Arimondo Molecular basis of the targeting of topoisomerase II-mediated DNA cleavage by VP16 derivatives conjugated to triplex-forming oligonucleotides. Nucleic Acids Res., January 1, 2006; 34(6): 1900 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suda, Y. Ito, T. Imai, T. Kikumori, A. Kikuchi, Y. Nishiyama, S. Yoshida, and M. Suzuki The {alpha}4 residues of human DNA topoisomerase II{alpha} function in enzymatic activity and anticancer drug sensitivity Nucleic Acids Res., March 16, 2004; 32(5): 1767 - 1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sengupta, M. Mukherjee, C. Mandal, A. Das, and H. K. Majumder Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani Nucleic Acids Res., September 15, 2003; 31(18): 5305 - 5316. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xiao, T.-K. Li, J.-M. Yang, and L. F. Liu Acidic pH induces topoisomerase II-mediated DNA damage PNAS, April 29, 2003; 100(9): 5205 - 5210. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Diaz, A. D. Alcid, J. M. Berger, and S. Keeney Identification of Residues in Yeast Spo11p Critical for Meiotic DNA Double-Strand Break Formation Mol. Cell. Biol., February 15, 2002; 22(4): 1106 - 1115. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||